BusinessJun 12, 2026
Bath & Body Works Is Running Into the Limits of Dominance
Rhea Lobo
Bath & Body Works is going through a beat-and-drop combination (when a company beats earnings estimates while reporting declining sales). Understanding it requires separating near-term profit improvement from a longer structural problem the company hasn't solved yet.
The US fine-fragrance market has grown over 40% in the last four years, per the Wall Street Journal.
Bath & Body Works is attempting to capture more of that growth by reformulating products, modernizing packaging, and scaling its influencer network from hundreds to thousands by summer.
Heaf expects that network to have a measurable impact on companywide sales in the second half of 2026. Store changes are also underway, with the company set to transform to a model that doesn't feel overwhelming.
CEO Daniel Heaf said the company is "in the early stages of transforming Bath & Body Works from a specialty retailer to a category-leading global brand."
Net income reached $183M in Q1, up over 74% year-over-year. The full-year outlook, however, remains negative. The company is guiding for net sales to decline between 2.5% and 4.5% through the fiscal year ending Jan. 30, 2027.
Body care, one of the brand's core categories, declined in the mid-teens during Q1. Goldman Sachs attributed the weakness partly to assortment and space limitations tied to brand collaborations, along with cuts to underperforming Everyday Luxuries products.
"The problem for BBW isn't that it's a terrible company or brand," said Neil Saunders, managing director of GlobalData. "On the contrary: it is a victim of its own success."
"BBW has such a high market share in some of its categories that it not only struggles to expand but also suffers from rival brands nibbling away at sales," Saunders added.
Digital sales represent only 20% of the company's annual revenue, a smaller share than rivals.
Saunders sees a more specific gap to close: the brand's "indulgent and treat" positioning needs to be paired with a more scientific approach to skin care and wellness, a segment that continues to see strong demand across the industry.
Management expects body care to return to growth by 2027, contingent on stronger innovation and a shift in marketing strategy.
Goldman Sachs lowered its price target on Bath & Body Works to $23 from $26, maintaining a Neutral rating. Telsey Advisory separately trimmed its target to $22 from $25, citing ongoing macroeconomic concerns and potential inflationary pressure.
Management is asking investors to price in a recovery that, by its own timeline, hasn't arrived yet.
